Pfizer - Quaterly Results

The quarter ended September 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 5885.90 millions.Net profit stood at Rs. 1583.50  millions  compared to Rs. 1489.60 millions in the corresponding previous quarter,high by 6.30%.OP of the company witnessed a marginal growth to 2323.20 millions from 2186.80 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202409	202309	% Var	202409	202309	% Var	202403	202303	% Var
Sales	5885.90	5752.10	2.33	11514.50	11065.70	4.06	21931.70	24247.60	-9.55
Other Income	430.70	360.70	19.41	849.10	695.30	22.12	1805.10	1010.50	78.63
PBIDT	2323.20	2186.80	6.24	4516.50	3628.50	24.47	8158.10	9099.10	-10.34
Interest	21.00	27.30	-23.08	42.10	56.00	-24.82	154.10	133.90	15.09
PBDT	2302.20	2159.50	6.61	4474.40	3572.50	25.25	8083.50	9295.20	-13.04
Depreciation	149.90	154.30	-2.85	295.90	309.80	-4.49	622.80	1055.10	-40.97
PBT	2152.30	2005.20	7.34	4178.50	3262.70	28.07	7460.70	8240.10	-9.46
TAX	568.80	515.60	10.32	1087.90	837.80	29.85	1947.40	2000.80	-2.67
Deferred Tax	-30.10	42.20	-171.33	-61.50	30.10	-304.32	361.10	-519.10	-169.56
PAT	1583.50	1489.60	6.30	3090.60	2424.90	27.45	5513.30	6239.30	-11.64
Equity	457.50	457.50	0.00	457.50	457.50	0.00	457.50	457.50	0.00
PBIDTM(%)	39.47	38.02	3.82	39.22	32.79	19.62	37.20	37.53	-0.87